The company said that gains in its Agilent CrossLab Group offset losses across its other two divisions as the company undertakes restructuring to grow as the market improves.

Called the Coalition for Effective Diagnostics, the organization has called on lawmakers to pass legislation revamping diagnostics regulation, including oversight of LDTs.

Last week, readers were most interested in a story about the development of an AI-based method to predict COPD flare-ups before symptoms appear.

According to the DOJ, Osman Syed submitted more than $79 million in fraudulent claims to Medicare and Texas Medicaid for RPP testing.

The company said that it is pairing its diagnostics and life sciences businesses to support growth and focus on shared end markets and customers.